Human trials of the Covid-19 vaccine will be starting in November as the country continues the fight against the pandemic, Ministry of Health officials have said.
According to the officials, the vaccine called, Self Replicating RNA, which has been made through a research conducted through a partnership between Uganda Virus Research Institute (UVRI) and Imperial College in the UK, will undergo three different steps before it is recommended for general public use.
Dr Diana Atwine, the permanent secretary in the Ministry of Health, said the people involved in the research are in the final stages of bringing the vaccine to Uganda for further trials before it is adopted by the World Health Organisation (WHO).
“I am waiting for a paper from UVRI and other research bodies in the country that have been put in place to give me the latest details, but what I know is by November, the vaccine shall be in the country ready for testing,” Dr Atwine said in an interview.
Recently, President Museveni formed the Presidential Scientific Initiative on Epidemics (PRESIDE) headed by Dr Monica Musenero to bolster research on Covid-19.